ENVERIC BIOSCIENCES

enveric-biosciences-logo

Enveric Biosciences is a patient-centric biotechnology company endeavoring to enhance the lives of those who are adversely affected by the side effects of cancer treatments. Enveric Biosciences has set out with the goal of rigorously testing natural compounds, starting with cannabinoids, to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs.

#SimilarOrganizations #People #Financial #Event #Website #More

ENVERIC BIOSCIENCES

Industry:
Biotechnology Health Care Life Science Medical

Founded:
1994-01-01

Address:
Naples, Florida, United States

Country:
United States

Website Url:
http://www.enveric.com

Total Employee:
251+

Status:
Active

Contact:
239-302-1707

Email Addresses:
[email protected]

Total Funding:
40.84 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics


Similar Organizations

arcellx-logo

Arcellx

Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.

axcella-logo

Axcella

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.


Current Advisors List

marcus-schabacker_image

Marcus Schabacker Board Member @ Enveric Biosciences
Board_member
2021-01-01

david-johnson_image

David Johnson Executive Chairman of The Board @ Enveric Biosciences
Board_member
2020-01-01

Current Employees Featured

avani-v-kanubaddi_image

Avani V. Kanubaddi
Avani V. Kanubaddi President & COO @ Enveric Biosciences
President & COO
2021-10-01

jillian-hagel_image

Jillian Hagel
Jillian Hagel Chief Technology Officer @ Enveric Biosciences
Chief Technology Officer
2021-09-01

bob-dagher_image

Bob Dagher
Bob Dagher Chief Medical Officer @ Enveric Biosciences
Chief Medical Officer
2021-12-01

carter-ward_image

Carter Ward
Carter Ward Chief Financial Officer @ Enveric Biosciences
Chief Financial Officer
2021-05-01

joseph-tucker_image

Joseph Tucker
Joseph Tucker Chief Executive Officer, Director @ Enveric Biosciences
Chief Executive Officer, Director

peter-facchini_image

Peter Facchini
Peter Facchini Chief Scientific Officer @ Enveric Biosciences
Chief Scientific Officer

Stock Details


Company's stock symbol is NASDAQ:ENVB

Acquisitions List

Date Company Article Price
2021-05-24 MagicMed Industries MagicMed Industries acquired by Enveric Biosciences 4 M CAD

Key Employee Changes

Date New article
2021-12-06 Enveric Biosciences Appoints Dr. Bob Dagher as Chief Medical Officer

Official Site Inspections

http://www.enveric.com Semrush global rank: 3.07 M Semrush visits lastest month: 5.26 K

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Enveric Biosciences"

Company Overview – Enveric Biosciences

Enveric has been able to optimize its discovery efforts and narrow down the potential compound variations in order to select the best neuroplastogen candidate molecules for specific …See details»

Investors – Enveric Biosciences

Leveraging its unique discovery and development platform, Psybrary™, Enveric has created a robust intellectual property portfolio of novel molecules for specific mental health indications. …See details»

Enveric Biosciences - Crunchbase Company Profile & Funding

Enveric Biosciences is a patient-centric biotechnology company endeavoring to enhance the lives of those who are adversely affected by the side effects of cancer treatments. Enveric …See details»

Enveric Biosciences Reports Financial Results and Provides …

1 day ago CAMBRIDGE, Mass., March 31, 2025--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of …See details»

Enveric Biosciences (ENVB) Company Profile & Description - Stock …

Mar 24, 2025 Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction …See details»

Enveric Biosciences Reports Financial Results and Provides

7 hours ago A discussion of these and other factors, including risks and uncertainties with respect to Enveric, is set forth in Enveric’s filings with the Securities and Exchange …See details»

Enveric Biosciences - Overview, News & Similar companies

May 21, 2024 Who is Enveric Biosciences. Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the …See details»

Enveric Biosciences, Inc. (ENVB) - Yahoo Finance

See the company profile for Enveric Biosciences, Inc. (ENVB) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»

Enveric Biosciences Reports Financial Results and Provides …

1 day ago CAMBRIDGE, Mass. – Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel …See details»

Enveric Biosciences Reports Financial Results and Provides …

1 day ago CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel …See details»

Enveric Biosciences, Inc. - LinkedIn

Enveric Biosciences, Inc. | 3,134 followers on LinkedIn. A New Approach to Solving Mental Health Challenges | Enveric Biosciences (NASDAQ: ENVB) is a biotechnology company dedicated to …See details»

Enveric Biosciences Inc, SLZG:BER profile - FT.com - Financial Times

Jan 27, 2025 Enveric Biosciences, Inc. is a biotechnology company. The Company is engaged in the development of novel neuroplastogenic small-molecule therapeutics for the treatment of …See details»

Enveric Biosciences - Craft

Enveric Biosciences Summary. Company Summary. Overview. Enveric Biosciences is a biotechnology company that specializes in drug development solutions. It develops …See details»

Enveric Biosciences, Inc. (ENVB) - Yahoo Finance Canada

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its …See details»

Corporate Governance – Enveric Biosciences

Mar 18, 2025 George Kegler Director, Chair of the Audit Committee. Mr. Kegler was employed by Mallinckrodt Pharmaceuticals from January 2013 – June 2019, serving as the Executive …See details»

Enveric Biosciences CEO Issues Letter to Shareholders

Feb 27, 2025 Enveric Biosciences, a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of anxiety, depression, …See details»

Enveric Biosciences Reports Financial Results and Provides …

1 day ago Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics …See details»

Enveric Biosciences - Overview, News & Similar companies

May 20, 2024 Enveric Biosciences to Participate in BIO International Convention 2024 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” …See details»

Enveric Biosciences Reports Financial Results and Provides …

1 day ago Enveric Biosciences ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the …See details»

Enveric posts $9.5M loss for 2024, but revenue could be on …

17 hours ago Florida-based psychedelics firm Enveric Biosciences (NASDAQ: ENVB), which is still in the pre-revenue stage, this week reported a $9.5 million net loss for 2024, down from …See details»

linkstock.net © 2022. All rights reserved